Diana Moroni

Mrs. Diana Moroni

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 February 2023 in Toxics
Verified
Journal Article
Open access
PDF file
DMDiana Moroni
Diana Moroni
VOVictor Enrique Sarmiento Ortega
Victor Enrique Sarmiento Ortega
ADAlfonso Diaz
Alfonso Diaz
EBEduardo Brambila
Eduardo Brambila
STSamuel Trevino
Samuel Trevino
Cadmium has been well recognized as a critical toxic agent in acute and chronic poisoning cases in occupational and nonoccupational settings and environmental exposure situations. Cadmium is released into the environment after natural and anthropogenic activities, particularly in contaminated and industrial areas, causing food pollution. In the body, cadmium has no biological activity, but it accumulates primarily in the liver and kidney, which are considered the main targets of its toxicity, through oxidative stress and inflammation. However, in the last few years, this metal has been linked to metabolic diseases. The pancreas–liver–adipose axis is largely affected by cadmium accumulation. Therefore, this review aims to collect bibliographic information that establishes the basis for understanding the molecular and cellular mechanisms linked to cadmium with carbohydrate, lipids, and endocrine impairments that contribute to developing insulin resistance, metabolic syndrome, prediabetes, and diabetes.

30 November 2021 in Biological Trace Element Research
Verified
Journal Article
Closed access
PDF file
VSVictor Enrique Sarmiento-Ortega
Victor Enrique Sarmiento-Ortega
DMDiana Moroni
Diana Moroni
ADAlfonso Diaz
Alfonso Diaz
EBEduardo Brambila
Eduardo Brambila
STSamuel Trevino
Samuel Trevino

10 September 2018 in Toxics
Verified
Journal Article
Open access
PDF file
VOVictor Enrique Sarmiento Ortega
Victor Enrique Sarmiento Ortega
EBEduardo Brambila
Eduardo Brambila
JFJosé Ángel Flores-Hernández
José Ángel Flores-Hernández
ADAlfonso Diaz
Alfonso Diaz
UPUlises Peña-Rosas
Ulises Peña-Rosas
STSamuel Trevino
Samuel Trevino
Previous studies have proposed that cadmium (Cd) is a metabolic disruptor, which is associated with insulin resistance, metabolic syndrome, and diabetes. This metal is not considered by international agencies for the study of metabolic diseases. In this study, we investigate the effect of metformin on Cd-exposed Wistar rats at a lowest-observed-adverse-effect level (LOAEL) dose (32.5 ppm) in drinking water. Metabolic complications in the rats exposed to Cd were dysglycemia, insulin resistance, dyslipidemia, dyslipoproteinemia, and imbalance in triglyceride and glycogen storage in the liver, muscle, heart, kidney, and adipose tissue. Meanwhile, rats treated orally with a No-observable-adverse-effect level (NOAEL) dose of metformin (200 mg/kg/day) showed mild improvement on serum lipids, but not on glucose tolerance; in tissues, glycogen storage was improved, but lipid storage was ineffective. In conclusion, metformin as a first-line pharmacological therapy must take into consideration the origin and duration of metabolic disruption, because in this work the NOAEL dose of metformin (200 mg/kg/day) showed a limited efficiency in the metabolic disruption caused by chronic Cd exposure.

6 August 2024 in Biological Trace Element Research
Verified
Journal Article
Open access
PDF file
VSVictor Enrique Sarmiento-Ortega
Victor Enrique Sarmiento-Ortega
DMDiana Moroni
Diana Moroni
ADAlfonso Diaz
Alfonso Diaz
EBEduardo Brambila
Eduardo Brambila
STSamuel Trevino
Samuel Trevino
Cadmium (Cd) is a global pollutant, and its accumulation in the liver causes oxidative stress, inflammation, insulin resistance (IR), and metabolic complications. This study investigated whether curcumin treatment could alleviate hepatic IR in Wistar rats exposed to sub-chronic cadmium and explored the underlying molecular pathways. Male Wistar rats were divided into a control group (standard normocaloric diet + cadmium-free water) and a cadmium group (standard normocaloric diet + drinking water with 32.5 ppm CdCl2) for 30 days. Oral glucose tolerance, insulin response, and IR were assessed using mathematical models. Liver tissue was analyzed for markers of oxidative stress, inflammation, and key regulatory pathways, including NF-κB, Nrf2, MAPKs (JNK and p38), and the IRS1-Akt pathway. We established an effective curcumin dose of 250 mg/kg for 5 days orally. Results demonstrated that after 30 days of exposure, cadmium accumulated in the liver, inducing an oxidative and inflammatory state. This was characterized by increased expression of NF-κB, JNK, and p38, along with diminished Nrf2 expression, hepatic IR, hyperglycemia, and hyperinsulinemia. Curcumin treatment effectively alleviated these metabolic disorders by restoring the balance between NF-κB and Nrf2 in the liver, modulating the MAPK pathway, and, consequently, improving oxidative and inflammatory balance. In conclusion, this study suggests that cadmium induces hepatic IR through an imbalance between NF-κB and Nrf2 signaling pathways. Curcumin treatment appears to improve these pathways, thereby ameliorating hepatic IR.

8 November 2022 in Biological Trace Element Research
Verified
Journal Article
Closed access
PDF file
VSVictor Enrique Sarmiento-Ortega
Victor Enrique Sarmiento-Ortega
DMDiana Moroni
Diana Moroni
ADAlfonso Diaz
Alfonso Diaz
EBEduardo Brambila
Eduardo Brambila
STSamuel Trevino
Samuel Trevino